Phase I Study of MT1011 Injection in Healthy Subjects

Clinical trial NCT07024160 · RECRUITING

Trial details

NCT number: NCT07024160
Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation

Start date: 2025-06-25
Primary completion: 2026-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.